Australia markets closed

Benitec Biopharma Inc. (BNTC)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
7.05+0.23 (+3.36%)
As of 02:50PM EDT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/06/2023
30/06/2022
30/06/2021
30/06/2020
Total revenue
61
75
73
59
97
Cost of revenue
-105
0
9
123
-185
Gross profit
166
75
64
-64
282
Operating expenses
Research development
15,884
12,774
11,272
7,020
3,001
Selling general and administrative
5,974
6,382
6,646
6,512
5,567
Total operating expenses
21,858
19,156
17,918
13,532
8,563
Operating income or loss
-21,692
-19,081
-17,854
-13,596
-8,281
Interest expense
27
33
32
6
-
Total other income/expenses net
-91
-448
-322
-280
-55
Income before tax
-21,810
-19,562
-18,208
-13,882
-8,274
Income from continuing operations
-21,810
-19,562
-18,208
-13,882
-8,274
Net income
-21,810
-19,562
-18,208
-13,882
-8,274
Net income available to common shareholders
-21,810
-19,562
-18,208
-13,882
-8,274
Basic EPS
-234.82
-240.04
-643.96
-54.91
-137.70
Diluted EPS
-234.82
-240.04
-643.96
-54.91
-137.70
Basic average shares
461.141
81.518
28.275
252.671
60.07
Diluted average shares
461.141
81.518
28.275
252.671
60.07